Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
28.02
+0.04 (0.14%)
At close: Sep 18, 2026, 4:00 PM EDT
27.92
-0.10 (-0.36%)
After-hours: Sep 18, 2026, 7:34 PM EDT
Mineralys Therapeutics Employees
Mineralys Therapeutics had 76 employees as of December 31, 2025. The number of employees increased by 25 or 49.02% compared to the previous year.
Employees
76
Change (1Y)
25
Growth (1Y)
49.02%
Revenue / Employee
n/a
Profits / Employee
-$4,599,684
Market Cap
2.48B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 76 | 25 | 49.02% |
| Dec 31, 2024 | 51 | 23 | 82.14% |
| Dec 31, 2023 | 28 | 16 | 133.33% |
| Dec 31, 2022 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Beam Therapeutics | 540 |
| Vera Therapeutics | 361 |
| Nurix Therapeutics | 317 |
| Harmony Biosciences Holdings | 293 |
| Structure Therapeutics | 281 |
| Viridian Therapeutics | 252 |
| Disc Medicine | 165 |
| Pharvaris | 148 |
MLYS News
- 9 days ago - Mineralys Therapeutics Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 9 days ago - Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 24 days ago - Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Mineralys Therapeutics reports Q2 EPS ($2.85), consensus (54c) - TheFly
- 4 weeks ago - Mineralys Therapeutics price target lowered to $49 from $51 at BofA - TheFly
- 5 weeks ago - Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Mineralys Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 5 weeks ago - Mineralys Therapeutics Earnings release: Q2 2026 - Filings